Cardiovascular & Nephrology area

Responsible for the affiliate P&L (Pain, Addiction, Critical Care)

=> Develop & execute regional commercial plan for Repatha® (CV area); Amgevita® (adalimumab Biosimilar) & Prolia® (osteoporosis)- Management & coaching of a team of 8 sales representatives (full team recruitment)- Development of business plans building on strong cross-functional approach; contribution to national programs- Change management to move the sales force to new markets & targets to support Amgevita® launch & Prolia® growth

Cardiovascular TA=> Develop & execute regional medical plan for evolocumab in Eastern France- Lead projects to support strategies & tactics (local ad boards with national OLs, key stakeholders education on clinical value and outcomes, speakers training, scientific engagement plan execution, Amgen sponsored research support…- Responsible for designing the medical plan of action for the French RML team

=> Prepare Amgen entry in cardiovascular area with Repatha (Direct report to FR General Manager, doted line report to Global marketing TA Head as AMG 145 Archetype Lead).-Engagement in the Global Commercial Strategic Team, giving input to shape the Global strategy and deliverables.-Lead French core team for Country launch readiness, LRP, P&L-Engagement with key external stakeholders-Development of multichannel approach

=> Nephrology Portfolio Life cycle management (Aranesp/ Mimpara)-Franchise management: develop marketing plan in a very competitive and evolving environment, strong cross-functional management, continuous products' positioning improvement, Amgen positioning as a key partner, advisory boards management & KOLs engagement, work with patients' advocacy, Nephrology Expenses optimization-Input to the EU marketing task force for both products-Management: prodct managers, 2 interns… Show more => Nephrology Portfolio Life cycle management (Aranesp/ Mimpara)-Franchise management: develop marketing plan in a very competitive and evolving environment, strong cross-functional management, continuous products' positioning improvement, Amgen positioning as a key partner, advisory boards management & KOLs engagement, work with patients' advocacy, Nephrology Expenses optimization-Input to the EU marketing task force for both products-Management: prodct managers, 2 interns, marketing assistant-Cross-disciplinary task lead at affiliate level: Biosimilar task force (establish road map), Multi-channel (assesment & recommendation) Show less

=> Maintained leadership facing new competition entry in market-Definition & implementation of French strategy to face new entry in market (new long acting ESA & Biosimilars)-Responsible for Business Unit operational programs

=> Launch Mimpara & develop penetration rate (1st launch rank in EU);=> Aranesp achievement of leadership-Drove marketing products' programs-Managed special operations: SureClick device launch; Mimpara switch management from hospital to retail

=> Developed Aranesp turnover in a territory unoccupied for 6 months-Achieved chairman reward in 2005/ second rank evolution in FR: from 31,4% MS to 50% MS (mean FR MS 42%)-Developed and roll out territory strategy and operational plan-Managed locally ESAs switch from hospital to retail market in pre dialysis segment